HomeNewscoronavirusCOVID-19 update | Mumbai logs less than 1,000 cases; positivity rate at 2.1%, active tally below 10,000

COVID-19 update | Mumbai logs less than 1,000 cases; positivity rate at 2.1%, active tally below 10,000

With this, the tally of coronavirus infections in the city rose to 10,46,590, while the death toll increased to 16,623, the Brihanmumbai Municipal Corporation (BMC) said in a bulletin.

January 31, 2022 / 20:47 IST
Story continues below Advertisement
Representative image
Representative image

Mumbai reported 960 new COVID-19 cases on Monday as daily count dropped below the 1,000-mark for the first time after December 27, 2021, while 11 more patients die due to the infection, the city civic body said.

With this, the tally of coronavirus infections in the city rose to 10,46,590, while the death toll increased to 16,623, the Brihanmumbai Municipal Corporation (BMC) said in a bulletin.In January 2022, Mumbai has reported 2,61,480 COVID-19 cases and 247 deaths as against 22,229 infections and 38 fatalities in December 2021, BMC data showed.

Story continues below Advertisement

ALSO READ: Over 7,700 properties registered in Mumbai in January 2022; number dips by 20% owing to Omicron

On the second day in a row, the daily COVID-19 cases have gone down in the financial capital. The city has reported 200 less cases than the count on Sunday, when it had registered 1,160 infections and 10 fatalities.The daily COVID-19 cases have dropped below the 1,000-mark for the first time after December 27, 2021, when Mumbai had logged 809 cases and three fatalities.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show